Platform trial rules out treatments for COVID-19, NIHR Evidence

This research shows that adding doxycycline, azithromycin or colchicine to usual care provides no meaningful benefit to people in the community with COVID-19. They should not be used. Antibiotics should always be used sparingly to prevent bacteria becoming resistant to them. Use of any drug which is not effective puts people at unnecessary risk of side effects, and wastes money.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news